Inhaled Nitric Oxide in Brain Injury
Primary Purpose
Traumatic Brain Injury
Status
Recruiting
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Inhaled Nitric Oxide
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Traumatic Brain Injury focused on measuring Mechanical ventilation, Inhaled nitric oxide
Eligibility Criteria
Inclusion Criteria:
- Hospital admission with traumatic brain injury (penetrating or blunt)
- Requirement for mechanical ventilation
- Glasgow Coma Score > 3
Exclusion Criteria:
- Brain death
- Expected survival < 48 hours
- Air leak (bronchopleural fistula, tracheal injury)
- Current inspired oxygen concentration (FiO2) > 0.65
- Hemodynamic instability (systolic blood pressure < 100 mm Hg, cardiac arrhythmia)
- Uncontrolled intracranial pressure (> 20 mm Hg)
- Spinal cord injury with hypotension
- Severe acute respiratory distress syndrome (ARDS) (PaO2/FiO2 < 100)
- Chest abbreviated injury score (AIS) > 3
- First rib fracture
- Flail chest
Sites / Locations
- University of CincinnatiRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Inhaled Nitric Oxide
Placebo
Arm Description
Inhaled nitric oxide at 20 parts per million, administered once during first 36 hours following admission
Nitrogen only, administered once during first 36 hours following admission
Outcomes
Primary Outcome Measures
Change in PaO2
The primary endpoint is a change in PaO2 of 20 percent or greater (yes/no)
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03260569
Brief Title
Inhaled Nitric Oxide in Brain Injury
Official Title
Respiratory Mechanics Following Brain Injury: The Role of Inhaled Nitric Oxide
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 12, 2018 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Cincinnati
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will evaluate the changes in respiratory mechanics following traumatic brain injury and determine the effect of inhaled nitric oxide on gas exchange.
Detailed Description
Intubation and mechanical ventilation are common treatments in the care of patients with traumatic brain injury (TBI). Intubation allows for airway control and facilitates removal of respiratory secretions. Mechanical ventilation allows control of arterial carbon dioxide to aid in control of intracranial pressure. Recent evidence suggests that lung protective ventilation (tidal volumes of 6 ml/kg of predicted body weight and moderate positive end expiratory pressure) improves outcomes following brain injury and reduces brain-lung cross talk.
The treatment of respiratory failure in TBI must balance the need to improve lung function with the negative consequences of increased intrathoracic pressure on mean arterial pressure, intracranial pressure and venous return. Traditional treatment of increasing positive end expiratory (PEEP) and mean airway pressure then, represent competing interests. Methods for improving arterial oxygenation while avoiding negative hemodynamic effects are needed.
The impact of head injury on respiratory mechanics has been studied in just a few clinical investigations. (1-3) Of note, the earliest of these noted that the ventilation perfusion (V/Q) matching following TBI was not the result of lung collapse or parenchymal lung disease but secondary to alterations in perfusion. There are three possibilities for this finding:
redistribution in regional perfusion, which is partially mediated by the hypothalamus
pulmonary microembolism, leading to increased dead space
lung surfactant depletion due to excessive sympathetic stimulation and hyperventilation.
The introduction of inhaled pulmonary vasodilators such as inhaled nitric oxide or aerosolized epoprostenol offer an opportunity to improve oxygenation in patients with TBI without increasing airway pressures in the face of V/Q inequalities.
This study will evaluate the changes in respiratory mechanics following TBI and determine the effect of inhaled nitric oxide on gas exchange.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Traumatic Brain Injury
Keywords
Mechanical ventilation, Inhaled nitric oxide
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
Following initial non-invasive measurements, patients will be randomized to either an active treatment (inhaled nitric oxide at 30 parts per million) or placebo (nitrogen only). After two hours, measurements will be reassessed. If the patient remains on the mechanical ventilator at 72 hours post-admission, a third set of non-invasive measurements will be taken.
Masking
ParticipantCare ProviderInvestigator
Masking Description
Both nitric oxide and placebo nitrogen will be made available in unmarked cylinders.
Allocation
Randomized
Enrollment
38 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Inhaled Nitric Oxide
Arm Type
Active Comparator
Arm Description
Inhaled nitric oxide at 20 parts per million, administered once during first 36 hours following admission
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Nitrogen only, administered once during first 36 hours following admission
Intervention Type
Drug
Intervention Name(s)
Inhaled Nitric Oxide
Intervention Description
Patients randomized to this arm will receive inhaled nitric oxide 20 parts per million.
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Nitrogen plus oxygen
Primary Outcome Measure Information:
Title
Change in PaO2
Description
The primary endpoint is a change in PaO2 of 20 percent or greater (yes/no)
Time Frame
Randomization through Day 3 of the study
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Hospital admission with traumatic brain injury (penetrating or blunt)
Requirement for mechanical ventilation
Glasgow Coma Score > 3
Exclusion Criteria:
Brain death
Expected survival < 48 hours
Air leak (bronchopleural fistula, tracheal injury)
Current inspired oxygen concentration (FiO2) > 0.65
Hemodynamic instability (systolic blood pressure < 100 mm Hg, cardiac arrhythmia)
Uncontrolled intracranial pressure (> 20 mm Hg)
Spinal cord injury with hypotension
Severe acute respiratory distress syndrome (ARDS) (PaO2/FiO2 < 100)
Chest abbreviated injury score (AIS) > 3
First rib fracture
Flail chest
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Michael D Goodman, MD
Phone
513-558-5661
Email
goodmanmd@uc.edu
Facility Information:
Facility Name
University of Cincinnati
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45267
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Carolina Rodriguez
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
420436
Citation
Schumacker PT, Rhodes GR, Newell JC, Dutton RE, Shah DM, Scovill WA, Powers SR. Ventilation-perfusion imbalance after head trauma. Am Rev Respir Dis. 1979 Jan;119(1):33-43. doi: 10.1164/arrd.1979.119.1.33.
Results Reference
background
PubMed Identifier
6346942
Citation
Cooper KR, Boswell PA. Accurate measurement of functional residual capacity and oxygen consumption of patients on mechanical ventilation. Anaesth Intensive Care. 1983 May;11(2):151-7. doi: 10.1177/0310057X8301100212.
Results Reference
background
PubMed Identifier
17053881
Citation
Koutsoukou A, Perraki H, Raftopoulou A, Koulouris N, Sotiropoulou C, Kotanidou A, Orfanos S, Roussos C. Respiratory mechanics in brain-damaged patients. Intensive Care Med. 2006 Dec;32(12):1947-54. doi: 10.1007/s00134-006-0406-0. Epub 2006 Oct 20.
Results Reference
background
PubMed Identifier
10199529
Citation
Gruber A, Reinprecht A, Illievich UM, Fitzgerald R, Dietrich W, Czech T, Richling B. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med. 1999 Mar;27(3):505-14. doi: 10.1097/00003246-199903000-00026.
Results Reference
background
PubMed Identifier
12855888
Citation
Holland MC, Mackersie RC, Morabito D, Campbell AR, Kivett VA, Patel R, Erickson VR, Pittet JF. The development of acute lung injury is associated with worse neurologic outcome in patients with severe traumatic brain injury. J Trauma. 2003 Jul;55(1):106-11. doi: 10.1097/01.TA.0000071620.27375.BE.
Results Reference
background
PubMed Identifier
15659943
Citation
Pelosi P, Severgnini P, Chiaranda M. An integrated approach to prevent and treat respiratory failure in brain-injured patients. Curr Opin Crit Care. 2005 Feb;11(1):37-42. doi: 10.1097/00075198-200502000-00006.
Results Reference
background
PubMed Identifier
25447937
Citation
Garry PS, Ezra M, Rowland MJ, Westbrook J, Pattinson KT. The role of the nitric oxide pathway in brain injury and its treatment--from bench to bedside. Exp Neurol. 2015 Jan;263:235-43. doi: 10.1016/j.expneurol.2014.10.017. Epub 2014 Oct 29.
Results Reference
background
PubMed Identifier
23188422
Citation
Terpolilli NA, Kim SW, Thal SC, Kuebler WM, Plesnila N. Inhaled nitric oxide reduces secondary brain damage after traumatic brain injury in mice. J Cereb Blood Flow Metab. 2013 Feb;33(2):311-8. doi: 10.1038/jcbfm.2012.176. Epub 2012 Nov 28.
Results Reference
background
PubMed Identifier
19222848
Citation
Papadimos TJ, Medhkour A, Yermal S. Successful use of inhaled nitric oxide to decrease intracranial pressure in a patient with severe traumatic brain injury complicated by acute respiratory distress syndrome: a role for an anti-inflammatory mechanism? Scand J Trauma Resusc Emerg Med. 2009 Feb 17;17:5. doi: 10.1186/1757-7241-17-5.
Results Reference
background
PubMed Identifier
18272001
Citation
Papadimos TJ. The beneficial effects of inhaled nitric oxide in patients with severe traumatic brain injury complicated by acute respiratory distress syndrome: a hypothesis. J Trauma Manag Outcomes. 2008 Jan 14;2(1):1. doi: 10.1186/1752-2897-2-1.
Results Reference
background
PubMed Identifier
11473859
Citation
Vavilala MS, Roberts JS, Moore AE, Newell DW, Lam AM. The influence of inhaled nitric oxide on cerebral blood flow and metabolism in a child with traumatic brain injury. Anesth Analg. 2001 Aug;93(2):351-3 , 3rd contents page. doi: 10.1097/00000539-200108000-00023.
Results Reference
background
PubMed Identifier
9428538
Citation
Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K Jr, Hyers TM, Papadakos P. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med. 1998 Jan;26(1):15-23. doi: 10.1097/00003246-199801000-00011.
Results Reference
background
PubMed Identifier
10501745
Citation
Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med. 1999 Sep;25(9):911-9. doi: 10.1007/s001340050982.
Results Reference
background
Learn more about this trial
Inhaled Nitric Oxide in Brain Injury
We'll reach out to this number within 24 hrs